These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 30379619)

  • 1. Systems-Wide Approaches in Induced Pluripotent Stem Cell Models.
    Lau E; Paik DT; Wu JC
    Annu Rev Pathol; 2019 Jan; 14():395-419. PubMed ID: 30379619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated analysis of mRNA, microRNA and protein in systemic lupus erythematosus-specific induced pluripotent stem cells from urine.
    Tang D; Chen Y; He H; Huang J; Chen W; Peng W; Lu Q; Dai Y
    BMC Genomics; 2016 Jul; 17():488. PubMed ID: 27402083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells.
    Tanaka A; Yuasa S; Node K; Fukuda K
    Int J Mol Sci; 2015 Aug; 16(8):18894-922. PubMed ID: 26274955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of mass spectrometry-based proteomics in the study of cellular reprogramming and induced pluripotent stem cells.
    Benevento M; Munoz J
    Expert Rev Proteomics; 2012 Aug; 9(4):379-99. PubMed ID: 22967076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-organizing map of gene regulatory networks for cell phenotypes during reprogramming.
    Zhang L; Zheng Y; Li D; Zhong Y
    Comput Biol Chem; 2011 Aug; 35(4):211-7. PubMed ID: 21864790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency.
    Leng L; Tan Y; Gong F; Hu L; Ouyang Q; Zhao Y; Lu G; Lin G
    Hum Reprod; 2015 Mar; 30(3):737-48. PubMed ID: 25586786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of iPSCs for Targeted Proteomic Analysis.
    Baud A; Heywood WE; Little D; Gissen P; Mills K
    Methods Mol Biol; 2019; 1994():131-139. PubMed ID: 31124110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of induced pluripotent stem cell technology for the investigation of hematological disorders.
    Dolatshad H; Tatwavedi D; Ahmed D; Tegethoff JF; Boultwood J; Pellagatti A
    Adv Biol Regul; 2019 Jan; 71():19-33. PubMed ID: 30341008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primate iPS cells as tools for evolutionary analyses.
    Wunderlich S; Kircher M; Vieth B; Haase A; Merkert S; Beier J; Göhring G; Glage S; Schambach A; Curnow EC; Pääbo S; Martin U; Enard W
    Stem Cell Res; 2014 May; 12(3):622-9. PubMed ID: 24631741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome Profiling Reveals Degree of Variability in Induced Pluripotent Stem Cell Lines: Impact for Human Disease Modeling.
    Schuster J; Halvardson J; Pilar Lorenzo L; Ameur A; Sobol M; Raykova D; Annerén G; Feuk L; Dahl N
    Cell Reprogram; 2015 Oct; 17(5):327-37. PubMed ID: 26348590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic Autism: Cellular and Molecular Phenotypes in Pluripotent Stem Cell-Derived Neurons.
    Liu X; Campanac E; Cheung HH; Ziats MN; Canterel-Thouennon L; Raygada M; Baxendale V; Pang AL; Yang L; Swedo S; Thurm A; Lee TL; Fung KP; Chan WY; Hoffman DA; Rennert OM
    Mol Neurobiol; 2017 Aug; 54(6):4507-4523. PubMed ID: 27356918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells.
    Kang X; Yu Q; Huang Y; Song B; Chen Y; Gao X; He W; Sun X; Fan Y
    PLoS One; 2015; 10(7):e0131128. PubMed ID: 26131765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe DCM phenotype of patient harboring RBM20 mutation S635A can be modeled by patient-specific induced pluripotent stem cell-derived cardiomyocytes.
    Streckfuss-Bömeke K; Tiburcy M; Fomin A; Luo X; Li W; Fischer C; Özcelik C; Perrot A; Sossalla S; Haas J; Vidal RO; Rebs S; Khadjeh S; Meder B; Bonn S; Linke WA; Zimmermann WH; Hasenfuss G; Guan K
    J Mol Cell Cardiol; 2017 Dec; 113():9-21. PubMed ID: 28941705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
    El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
    Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells.
    Pfaff N; Lachmann N; Kohlscheen S; Sgodda M; Araúzo-Bravo MJ; Greber B; Kues W; Glage S; Baum C; Niemann H; Schambach A; Cantz T; Moritz T
    Stem Cells Dev; 2012 Mar; 21(5):689-701. PubMed ID: 21732815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics in the World of Induced Pluripotent Stem Cells.
    Lindoso RS; Kasai-Brunswick TH; Monnerat Cahli G; Collino F; Bastos Carvalho A; Campos de Carvalho AC; Vieyra A
    Cells; 2019 Jul; 8(7):. PubMed ID: 31336746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced Pluripotent Stem Cells in Disease Modeling and Gene Identification.
    Kumar S; Blangero J; Curran JE
    Methods Mol Biol; 2018; 1706():17-38. PubMed ID: 29423791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome.
    Liang P; Sallam K; Wu H; Li Y; Itzhaki I; Garg P; Zhang Y; Vermglinchan V; Lan F; Gu M; Gong T; Zhuge Y; He C; Ebert AD; Sanchez-Freire V; Churko J; Hu S; Sharma A; Lam CK; Scheinman MM; Bers DM; Wu JC
    J Am Coll Cardiol; 2016 Nov; 68(19):2086-2096. PubMed ID: 27810048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the genic and metabolic characteristics of induced pluripotent stem cells from polycystic ovary syndrome women.
    Min Z; Gao Q; Zhen X; Fan Y; Tan T; Li R; Zhao Y; Yu Y
    Stem Cell Res Ther; 2018 Aug; 9(1):210. PubMed ID: 30092830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.